Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
暂无分享,去创建一个
E. Masliah | E. Rockenstein | R. Rissman | B. Spencer | A. Adame | Deborah Masliah | J. Fields | Seung-Jae Lee | M. Iba | M. Mante | Changyoun Kim | H. Yamakado | He‐Jin Lee